Steven Y Lin
Family Practice · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 1 carrier
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
12 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Steven Y Lin’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A118924 · Current
Licensed to practise in California · since 2011 · expires 2027-11-30 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$12,793
Medicare paid this office $12,793 for 142 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 98 | $6,229 | $64 |
| Return visit (30+ min) | 36 | $2,667 | $54 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 11 | $865 | $79 |
| Return visit (30+ min) | 12 | $825 | $63 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 16 | $270 | $15 |
Procedures Medicare counted
| Removal of skin lesions | 1-10 | None |
| Removal or shaving of skin growth | 1-10 | None |
Who their Medicare patients are
142 Original Medicare patients in 2024. Average age 75 · Under 65 8% · 85 and older 12% · Women 39% · Also on Medicaid 21% · Health risk score 0.92. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 49% · Diabetes 25% · Coronary heart disease 14% · Cancer 14% · Chronic kidney disease 12% · Atrial fibrillation 11% · Depression 11%.
The office billed $101,006, Medicare allowed $16,591 and paid $12,793; for 223 services of 9 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 142 | 223 | 75 | 0.92 | $101,006 | $12,793 |
| 2023 | 128 | 205 | 74 | 0.93 | $89,732 | $10,832 |
| 2022 | 168 | 288 | 74 | 0.87 | $132,971 | $18,670 |
| 2021 | 143 | 245 | 74 | 0.87 | $119,377 | $16,371 |
| 2020 | 137 | 254 | 73 | 0.93 | $76,289 | $16,806 |
| 2019 | 134 | 220 | 73 | 0.93 | $38,619 | $14,825 |
| 2018 | 143 | 284 | 72 | 0.97 | $49,983 | $19,197 |
| 2017 | 141 | 260 | 73 | 1.32 | $60,403 | $17,439 |
| 2016 | 154 | 331 | 72 | 1.20 | $82,085 | $22,270 |
| 2015 | 133 | 279 | 72 | 1.04 | $66,282 | $18,834 |
| 2014 | 117 | 230 | 69 | 0.98 | $54,681 | $15,605 |
| 2013 | 47 | 67 | 71 | 1.11 | $15,818 | $5,120 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 90 | $5,004 | $56 |
| Return visit (30+ min) | 53 | $3,953 | $51 |
2022: 4 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 102 | $7,189 | $70 |
| Return visit (30+ min) | 70 | $5,826 | $55 |
| Telephone medical discussion with physician, 21-30 minutes | 11 | $1,062 | $89 |
| Long return visit (40+ min) | 13 | $801 | $57 |
2021: 4 services
| Return visit (30+ min) | 66 | $6,667 | $62 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 68 | $5,284 | $78 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 14 | $1,158 | $83 |
| Short return visit (20+ min) | 15 | $860 | $54 |
2020: 5 services
| Return visit (30+ min) | 79 | $8,024 | $62 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 22 | $3,144 | $143 |
| Telephone medical discussion with physician, 21-30 minutes | 16 | $1,133 | $63 |
| Short return visit (20+ min) | 20 | $991 | $47 |
| Telephone medical discussion with physician, 11-20 minutes | 20 | $791 | $33 |
2019: 3 services
| Return visit (30+ min) | 95 | $8,794 | $58 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 24 | $3,387 | $141 |
| Short return visit (20+ min) | 17 | $743 | $41 |
2018: 3 services
| Return visit (30+ min) | 96 | $8,787 | $56 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 22 | $3,088 | $140 |
| Return visit (30+ min) | 41 | $2,967 | $69 |
2017: 4 services
| Return visit (30+ min) | 101 | $9,147 | $55 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 29 | $4,017 | $139 |
| Long return visit (40+ min) | 11 | $1,096 | $91 |
| New patient visit (45+ min) | 11 | $1,040 | $95 |
2016: 4 services
| Return visit (30+ min) | 114 | $12,788 | $57 |
| Long return visit (40+ min) | 15 | $2,378 | $99 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 17 | $2,340 | $138 |
| Short return visit (20+ min) | 21 | $765 | $35 |
2015: 4 services
| Return visit (30+ min) | 86 | $11,272 | $61 |
| New patient visit (45+ min) | 20 | $1,602 | $80 |
| Long return visit (40+ min) | 11 | $1,493 | $100 |
| Short return visit (20+ min) | 18 | $774 | $43 |
2014: 3 services
| Return visit (30+ min) | 87 | $8,831 | $58 |
| New patient visit (45+ min) | 23 | $1,806 | $79 |
| Short return visit (20+ min) | 12 | $546 | $42 |
2013: 1 service
| Return visit (30+ min) | 30 | $2,706 | $64 |
Medicaid work
$58 in 2022
Medicaid paid $58 for 13 billed services this clinician did in 2022, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 13 | $58 |
| 2022 | 13 | 1 | 13 | $58 |
| 2021 | 13 | 1 | 12 | $256 |
| 2019 | 14 | 1 | 14 | $184 |
See the largest Medicaid services in earlier years
2021
| Return visit (30+ min) | 13 | $256 |
2019
| Return visit (30+ min) | 14 | $184 |
Drugs they prescribed that Part D paid
$169,787
Pharmacies billed $169,787 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (33 of 1,421) in 2024. Above the middle of the specialty; the typical family practice clinician is at 2%.
1,226 generic and 182 brand-name prescriptions · $169,787 in drug cost · 16 antibiotic prescriptions to 11 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 17 | $21,465 | $1,263 |
| Ozempic | 13 | $19,018 | $1,463 |
| Tamsulosin | 53 | $1,605 | $30 |
| Synthroid | 14 | $1,559 | $111 |
| Atorvastatin | 137 | $1,338 | $10 |
See all 29 drugs
| Eliquis | 17 | $21,465 | $1,263 |
| Ozempic | 13 | $19,018 | $1,463 |
| Tamsulosin | 53 | $1,605 | $30 |
| Synthroid | 14 | $1,559 | $111 |
| Atorvastatin | 137 | $1,338 | $10 |
| Rosuvastatin | 35 | $973 | $28 |
| Morphine Sulfate | 12 | $742 | $62 |
| Amlodipine Besylate | 108 | $722 | $7 |
| Levothyroxine | 57 | $713 | $13 |
| Pantoprazole | 33 | $581 | $18 |
| Metoprolol | 33 | $554 | $17 |
| Gabapentin | 21 | $514 | $24 |
| Lisinopril | 65 | $508 | $8 |
| Simvastatin | 17 | $502 | $30 |
| Losartan | 61 | $469 | $8 |
| Fluocinonide | 11 | $462 | $42 |
| Pravastatin | 46 | $447 | $10 |
| Finasteride | 20 | $439 | $22 |
| Dutasteride | 16 | $383 | $24 |
| Omeprazole | 31 | $344 | $11 |
| Alendronate | 24 | $260 | $11 |
| Metformin Hcl Er | 20 | $247 | $12 |
| Metformin | 29 | $227 | $8 |
| Clopidogrel | 11 | $225 | $20 |
| Furosemide | 18 | $115 | $6 |
| Tramadol | 14 | $80 | $6 |
| Triamcinolone Acetonide | 17 | $62 | $4 |
| Metoprolol | 12 | $28 | $2 |
| Lorazepam | 11 | $24 | $2 |
Year by year
| 2024 | 1,421 | 140 | 2% (33) | 13% | $169,787 |
| 2023 | 1,514 | 166 | 3% (46) | 10% | $157,519 |
| 2022 | 1,547 | 189 | 3% (53) | 10% | $151,770 |
| 2021 | 1,585 | 145 | 4% (56) | 12% | $142,520 |
| 2020 | 1,664 | 154 | 4% (70) | None | $120,076 |
| 2019 | 1,434 | 143 | 3% (44) | None | $125,537 |
| 2018 | 1,368 | 154 | 4% (51) | None | $110,238 |
| 2017 | 1,096 | 143 | 5% (51) | None | $100,198 |
| 2016 | 1,002 | 137 | 4% (44) | None | $82,029 |
| 2015 | 704 | 93 | 4% (25) | 20% | $55,098 |
| 2014 | 482 | 86 | None | None | $34,342 |
| 2013 | 316 | 72 | 4% (11) | None | $11,890 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 26 drugs
| Eliquis | 13 | $21,480 | $1,652 |
| Tamsulosin | 66 | $2,846 | $43 |
| Gabapentin | 36 | $2,833 | $79 |
| Atorvastatin | 126 | $1,861 | $15 |
| Amlodipine Besylate | 103 | $1,496 | $15 |
| Pravastatin | 51 | $1,278 | $25 |
| Losartan | 58 | $1,205 | $21 |
| Dutasteride | 25 | $1,161 | $46 |
| Metoprolol | 47 | $1,023 | $22 |
| Levothyroxine | 53 | $986 | $19 |
| Finasteride | 28 | $943 | $34 |
| Omeprazole | 35 | $867 | $25 |
| Lisinopril | 59 | $857 | $15 |
| Morphine Sulfate | 12 | $819 | $68 |
| Rosuvastatin | 30 | $719 | $24 |
| Metformin Hcl Er | 28 | $614 | $22 |
| Alendronate | 30 | $462 | $15 |
| Tramadol | 22 | $426 | $19 |
| Simvastatin | 12 | $425 | $35 |
| Pantoprazole | 29 | $366 | $13 |
| Metformin | 33 | $351 | $11 |
| Zolpidem | 16 | $231 | $14 |
| Carvedilol | 16 | $183 | $11 |
| Paxlovid (Eua) | 13 | $95 | $7 |
| Hydrochlorothiazide | 12 | $62 | $5 |
| Sildenafil Citrate | 17 | $39 | $2 |
2022: 34 drugs
| Gabapentin | 41 | $1,713 | $42 |
| Tamsulosin | 50 | $1,408 | $28 |
| Pravastatin | 68 | $1,310 | $19 |
| Dutasteride | 21 | $1,304 | $62 |
| Atorvastatin | 130 | $1,231 | $9 |
| Synthroid | 11 | $1,019 | $93 |
| Amlodipine Besylate | 101 | $990 | $10 |
| Levothyroxine | 48 | $930 | $19 |
| Losartan | 67 | $801 | $12 |
| Lisinopril | 81 | $752 | $9 |
| Morphine Sulfate | 12 | $693 | $58 |
| Metoprolol | 36 | $657 | $18 |
| Finasteride | 28 | $601 | $21 |
| Rosuvastatin | 29 | $560 | $19 |
| Morphine Sulfate Er | 11 | $511 | $46 |
| Diclofenac | 17 | $405 | $24 |
| Clopidogrel | 15 | $365 | $24 |
| Pantoprazole | 25 | $364 | $15 |
| Simvastatin | 17 | $339 | $20 |
| Omeprazole | 27 | $287 | $11 |
| Metformin | 33 | $233 | $7 |
| Alendronate | 24 | $209 | $9 |
| Carvedilol | 24 | $146 | $6 |
| Nitroglycerin | 12 | $142 | $12 |
| Naproxen | 16 | $133 | $8 |
| Triamcinolone Acetonide | 23 | $121 | $5 |
| Tramadol | 15 | $98 | $7 |
| Furosemide | 20 | $88 | $4 |
| Zolpidem | 18 | $76 | $4 |
| Hydrochlorothiazide | 14 | $53 | $4 |
| Warfarin | 11 | $39 | $4 |
| Lorazepam | 12 | $31 | $3 |
| Hydrocodone-Acetaminophen | 11 | $29 | $3 |
| Alprazolam | 11 | $21 | $2 |
2021: 36 drugs
| Jublia | 14 | $18,998 | $1,357 |
| Victoza 3-Pak | 11 | $12,365 | $1,124 |
| Pradaxa | 13 | $6,555 | $504 |
| Atorvastatin | 136 | $2,062 | $15 |
| Dutasteride | 27 | $1,705 | $63 |
| Pravastatin | 83 | $1,479 | $18 |
| Synthroid | 14 | $1,431 | $102 |
| Tamsulosin | 58 | $1,303 | $22 |
| Rosuvastatin | 31 | $1,239 | $40 |
| Diclofenac | 35 | $1,218 | $35 |
| Amlodipine Besylate | 102 | $1,016 | $10 |
| Levothyroxine | 39 | $965 | $25 |
| Gabapentin | 37 | $928 | $25 |
| Losartan | 66 | $909 | $14 |
| Morphine Sulfate Er | 11 | $678 | $62 |
| Lisinopril | 66 | $651 | $10 |
| Morphine Sulfate | 11 | $646 | $59 |
| Omeprazole | 37 | $628 | $17 |
| Zolpidem | 22 | $543 | $25 |
| Escitalopram | 16 | $474 | $30 |
| Pantoprazole | 19 | $443 | $23 |
| Metoprolol | 29 | $443 | $15 |
| Finasteride | 17 | $428 | $25 |
| Simvastatin | 16 | $426 | $27 |
| Losartan-Hydrochlorothiazide | 13 | $368 | $28 |
| Tramadol | 20 | $249 | $12 |
| Alendronate | 31 | $212 | $7 |
| Metoprolol | 13 | $208 | $16 |
| Carvedilol | 15 | $169 | $11 |
| Fluoxetine | 12 | $144 | $12 |
| Metformin | 31 | $139 | $4 |
| Donepezil | 14 | $120 | $9 |
| Furosemide | 16 | $107 | $7 |
| Ibuprofen | 12 | $84 | $7 |
| Hydrochlorothiazide | 14 | $70 | $5 |
| Triamcinolone Acetonide | 14 | $64 | $5 |
2020: 40 drugs
| Pradaxa | 11 | $5,223 | $475 |
| Rosuvastatin | 29 | $2,532 | $87 |
| Atorvastatin | 118 | $1,929 | $16 |
| Dutasteride | 24 | $1,775 | $74 |
| Synthroid | 17 | $1,677 | $99 |
| Levothyroxine | 48 | $1,281 | $27 |
| Pravastatin | 82 | $1,260 | $15 |
| Tamsulosin | 58 | $1,096 | $19 |
| Losartan | 80 | $956 | $12 |
| Gabapentin | 43 | $932 | $22 |
| Amlodipine Besylate | 112 | $823 | $7 |
| Loperamide | 11 | $771 | $70 |
| Albuterol Sulfate Hfa | 11 | $745 | $68 |
| Lisinopril | 80 | $727 | $9 |
| Morphine Sulfate | 13 | $719 | $55 |
| Diclofenac | 14 | $706 | $50 |
| Metoprolol | 29 | $669 | $23 |
| Omeprazole | 43 | $396 | $9 |
| Metformin | 38 | $343 | $9 |
| Simvastatin | 17 | $342 | $20 |
| Metoprolol | 19 | $325 | $17 |
| Alendronate | 35 | $308 | $9 |
| Tramadol | 40 | $262 | $7 |
| Finasteride | 14 | $259 | $19 |
| Escitalopram | 15 | $208 | $14 |
| Pantoprazole | 18 | $184 | $10 |
| Montelukast | 15 | $182 | $12 |
| Fluticasone Propionate | 11 | $168 | $15 |
| Memantine | 12 | $164 | $14 |
| Zolpidem | 35 | $142 | $4 |
| Temazepam | 15 | $139 | $9 |
| Furosemide | 14 | $119 | $8 |
| Triamcinolone Acetonide | 14 | $110 | $8 |
| Carvedilol | 15 | $91 | $6 |
| Donepezil | 14 | $75 | $5 |
| Glipizide | 11 | $73 | $7 |
| Fluoxetine | 13 | $67 | $5 |
| Hydrochlorothiazide | 14 | $64 | $5 |
| Cyclobenzaprine | 12 | $56 | $5 |
| Sulfamethoxazole-Trimethoprim | 11 | $33 | $3 |
2019: 36 drugs
| Januvia | 16 | $20,591 | $1,287 |
| Pradaxa | 12 | $5,251 | $438 |
| Atorvastatin | 97 | $1,934 | $20 |
| Dutasteride | 21 | $1,767 | $84 |
| Rosuvastatin | 22 | $1,555 | $71 |
| Bupropion Xl | 11 | $1,290 | $117 |
| Tamsulosin | 57 | $1,234 | $22 |
| Amlodipine Besylate | 112 | $1,206 | $11 |
| Pravastatin | 60 | $1,180 | $20 |
| Proair Hfa | 15 | $1,100 | $73 |
| Losartan | 76 | $893 | $12 |
| Metoprolol | 27 | $883 | $33 |
| Loperamide | 12 | $841 | $70 |
| Levothyroxine | 32 | $787 | $25 |
| Gabapentin | 28 | $765 | $27 |
| Lisinopril | 81 | $689 | $9 |
| Omeprazole | 36 | $645 | $18 |
| Morphine Sulfate | 12 | $573 | $48 |
| Escitalopram | 12 | $564 | $47 |
| Metformin | 37 | $457 | $12 |
| Montelukast | 17 | $449 | $26 |
| Zolpidem | 30 | $333 | $11 |
| Fluticasone Propionate | 19 | $310 | $16 |
| Finasteride | 15 | $303 | $20 |
| Pantoprazole | 12 | $290 | $24 |
| Simvastatin | 15 | $286 | $19 |
| Metoprolol | 20 | $283 | $14 |
| Memantine | 12 | $240 | $20 |
| Carvedilol | 14 | $224 | $16 |
| Alendronate | 22 | $160 | $7 |
| Losartan-Hydrochlorothiazide | 12 | $136 | $11 |
| Tramadol | 21 | $119 | $6 |
| Fluoxetine | 15 | $101 | $7 |
| Hydrochlorothiazide | 12 | $86 | $7 |
| Donepezil | 16 | $85 | $5 |
| Furosemide | 11 | $79 | $7 |
2018: 27 drugs
| Januvia | 12 | $14,385 | $1,199 |
| Atorvastatin | 79 | $1,880 | $24 |
| Rosuvastatin | 12 | $1,704 | $142 |
| Pravastatin | 64 | $1,616 | $25 |
| Tamsulosin | 45 | $1,220 | $27 |
| Amlodipine Besylate | 108 | $961 | $9 |
| Losartan | 71 | $780 | $11 |
| Loperamide | 11 | $778 | $71 |
| Levothyroxine | 33 | $753 | $23 |
| Gabapentin | 23 | $731 | $32 |
| Metoprolol | 21 | $597 | $28 |
| Lisinopril | 76 | $559 | $7 |
| Escitalopram | 11 | $500 | $45 |
| Omeprazole | 27 | $457 | $17 |
| Simvastatin | 16 | $436 | $27 |
| Metformin | 39 | $435 | $11 |
| Finasteride | 16 | $401 | $25 |
| Pantoprazole | 17 | $269 | $16 |
| Morphine Sulfate | 12 | $239 | $20 |
| Fluticasone Propionate | 19 | $207 | $11 |
| Metoprolol | 22 | $172 | $8 |
| Zolpidem | 31 | $169 | $5 |
| Alendronate | 21 | $127 | $6 |
| Donepezil | 19 | $123 | $6 |
| Tramadol | 15 | $121 | $8 |
| Fluoxetine | 14 | $77 | $6 |
| Furosemide | 11 | $36 | $3 |
2017: 25 drugs
| Spiriva | 12 | $11,488 | $957 |
| Tamsulosin | 47 | $1,836 | $39 |
| Pravastatin | 46 | $1,628 | $35 |
| Atorvastatin | 56 | $1,426 | $25 |
| Rosuvastatin | 15 | $1,202 | $80 |
| Amlodipine Besylate | 84 | $882 | $11 |
| Gabapentin | 17 | $825 | $49 |
| Levothyroxine | 24 | $777 | $32 |
| Metoprolol | 19 | $655 | $34 |
| Losartan | 51 | $653 | $13 |
| Lisinopril | 73 | $608 | $8 |
| Simvastatin | 16 | $452 | $28 |
| Metformin | 35 | $444 | $13 |
| Pantoprazole | 11 | $362 | $33 |
| Finasteride | 12 | $293 | $24 |
| Morphine Sulfate | 12 | $277 | $23 |
| Alendronate | 19 | $176 | $9 |
| Carvedilol | 19 | $165 | $9 |
| Clopidogrel | 12 | $148 | $12 |
| Metoprolol | 16 | $144 | $9 |
| Tramadol | 19 | $139 | $7 |
| Atenolol | 19 | $128 | $7 |
| Zolpidem | 19 | $112 | $6 |
| Hydrochlorothiazide | 14 | $50 | $4 |
| Furosemide | 12 | $29 | $2 |
2016: 23 drugs
| Nexium | 19 | $7,272 | $383 |
| Crestor | 11 | $6,096 | $554 |
| Tamsulosin | 38 | $1,877 | $49 |
| Pravastatin | 42 | $1,756 | $42 |
| Atorvastatin | 56 | $1,403 | $25 |
| Loperamide | 13 | $919 | $71 |
| Amlodipine Besylate | 74 | $788 | $11 |
| Morphine Sulfate | 13 | $758 | $58 |
| Lisinopril | 67 | $743 | $11 |
| Dutasteride | 12 | $677 | $56 |
| Metoprolol | 21 | $674 | $32 |
| Levothyroxine | 18 | $590 | $33 |
| Losartan | 43 | $545 | $13 |
| Metformin | 21 | $316 | $15 |
| Omeprazole | 13 | $178 | $14 |
| Alendronate | 19 | $173 | $9 |
| Fluticasone Propionate | 14 | $149 | $11 |
| Tramadol | 20 | $141 | $7 |
| Simvastatin | 15 | $135 | $9 |
| Carvedilol | 13 | $116 | $9 |
| Metoprolol | 11 | $107 | $10 |
| Triamcinolone Acetonide | 15 | $74 | $5 |
| Zolpidem | 14 | $59 | $4 |
2015: 22 drugs
| Spiriva | 17 | $8,290 | $488 |
| Januvia | 15 | $5,887 | $392 |
| Pravastatin | 27 | $1,182 | $44 |
| Tamsulosin | 27 | $1,066 | $39 |
| Oxycodone-Acetaminophen | 11 | $840 | $76 |
| Diphenoxylate-Atropine | 13 | $715 | $55 |
| Atorvastatin | 28 | $623 | $22 |
| Amlodipine Besylate | 61 | $477 | $8 |
| Loperamide | 11 | $437 | $40 |
| Lisinopril | 39 | $419 | $11 |
| Levothyroxine | 16 | $403 | $25 |
| Losartan | 33 | $388 | $12 |
| Omeprazole | 18 | $267 | $15 |
| Fluticasone Propionate | 16 | $172 | $11 |
| Zolpidem | 15 | $172 | $11 |
| Atenolol | 19 | $170 | $9 |
| Metformin | 12 | $152 | $13 |
| Carvedilol | 12 | $124 | $10 |
| Alendronate | 11 | $106 | $10 |
| Metoprolol | 12 | $101 | $8 |
| Hydrochlorothiazide | 13 | $60 | $5 |
| Clonazepam | 12 | $28 | $2 |
2014: 13 drugs
| Pravastatin | 25 | $1,035 | $41 |
| Losartan | 16 | $613 | $38 |
| Atorvastatin | 18 | $500 | $28 |
| Tamsulosin | 13 | $368 | $28 |
| Amlodipine Besylate | 33 | $318 | $10 |
| Fluticasone Propionate | 17 | $306 | $18 |
| Omeprazole | 11 | $283 | $26 |
| Lisinopril | 30 | $264 | $9 |
| Atenolol | 15 | $126 | $8 |
| Hydrochlorothiazide | 17 | $107 | $6 |
| Metformin | 11 | $84 | $8 |
| Clonazepam | 11 | $73 | $7 |
| Zolpidem | 11 | $58 | $5 |
2013: 9 drugs
| Pravastatin | 15 | $253 | $17 |
| Amlodipine Besylate | 22 | $170 | $8 |
| Losartan | 16 | $163 | $10 |
| Levothyroxine | 11 | $142 | $13 |
| Simvastatin | 16 | $104 | $7 |
| Glipizide | 14 | $91 | $7 |
| Metoprolol | 15 | $85 | $6 |
| Metformin | 12 | $81 | $7 |
| Furosemide | 13 | $52 | $4 |
Professional record
- NPI
- 1851668255
- Licence
- CA A118924California A118924: Current · expires 2027-11-30
- Trained
- Stanford University School of Medicine, 2010
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2011-11-30
- NPI last updated
- 2024-04-12
- NPI record certified
- 2024-04-12
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 211 Quarry Rd, Palo Alto, CA, 94304